Themis starts Phase II clinical study of Chikungunya vaccine in endemic area27. July 2017|In Portfolio News|By eazee-designstudioA promising prophylactic vaccine candidate against Chikungunya fever will be tested from August on in a Phase II clinical study in Puerto Rico, a Chikungunya fever endemic area. PrevNext
